Michael Garanzini Net Worth & Insider Trades

Michael Garanzini - Chief Commercial Officer, Eyegate Pharmaceuticals Inc

As of July 12, 2018

What is Michael Garanzini's Net Worth?

The current estimated net worth of Eyegate Pharmaceuticals Inc's Chief Commercial Officer, Michael Garanzini, is estimated to be about $406 . Michael Garanzini owns about 171,250 units of Eyegate Pharmaceuticals Inc common stock. In the last year at Eyegate Pharmaceuticals Inc, Michael Garanzini has sold an estimated value of $0 worth.

What is Michael Garanzini's Past Insider Trading?

In total, Michael Garanzini has made about 4 transactions over a year of their time at Eyegate Pharmaceuticals Inc. Michael Garanzini usually trades in November, with the busiest year in 2018 and 2017. The most recent transaction was a purchase order of 156,250 units , worth over $0 on April 18, 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Michael Garanzini's Salary in 2020 ?

As Chief Commercial Officer of Eyegate Pharmaceuticals Inc, Michael Garanzini has a total base salary of $250,000 . Michael Garanzini received compensation valued at about $406,962 in 2020 after becoming Chief Commercial Officer. The vast majority of their compensation came in the form of a bonus of $60,000 , stock awards of $48,481 , option awards of $48,481 , and

What is Michael Garanzini's' Mailing Address?

  • Mailing address is 271 Waverly Oaks Road Suite 108 Waltham MA 02452 MA

Eyegate Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Stephen From 2020 $400,000 $160,000 $129,282 $193,923 - $883,205
Stephen From 2019 $400,000 $106,600 - $94,740 - $601,340
Sarah Romano 2020 $264,361 $60,000 $64,641 $64,641 - $453,643
Sarah Romano 2019 $250,000 $86,010 - $23,685 - $359,695
Michael Manzo 2020 $250,000 $60,000 $48,481 $48,481 - $406,962
Michael Manzo 2019 $250,000 $94,167 - $23,685 - $367,852
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1372514/000110465921058990/tm2114484-1_def14a.htm

What are Eyegate Pharmaceuticals Inc's Past Insider Trades?

Eyegate Pharmaceuticals Inc's most recent insider trade came on August 3, 2021 by Armistice Capital Llc, Armistice Capital Master Fund Ltd and Steven Boyd who sold 260,963 units worth $646.61K . In the last 6 years, insiders at Eyegate Pharmaceuticals Inc have sold an estimated value of $15.73M and bought an estimated value of $20.29M worth of shares. Insider trading is most common in February, with the busiest year in 2020. The most active traders at the company are Stephen From, Executive Chairman,  Michael Manzo, VP Engineering,  and Brenda Mann, VP Research & Development .

EYEGATE PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1